Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta 2 microglobulin in CAPD.

J Montenegro1, I Martínez, R Saracho

  • 1Nephrology Department, Hospital de Galdakao, Galdácano Vizcaya, Spain.

Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual evoked potentials and development on children with congenital cataract with surgery after 4 months of age.

Archivos de la Sociedad Espanola de Oftalmologia·2025
Same author

Inhibition of calreticulin by protein nanoparticles carrying antisense oligonucleotides reduce gene expression and infection of <i>Trypanosoma cruzi</i> trypomastigotes on mammalian cells.

Nanomedicine (London, England)·2025
Same author

Production of poly-3-hydroxybutyrate (PHB) nanoparticles using grape residues as the sole carbon source.

International journal of biological macromolecules·2024
Same author

Clinical findings, surgical treatment and outcome in dogs with parotid duct ectasia: 14 cases (2010-2023).

The Journal of small animal practice·2023
Same author

[Translated article] Tumor ablation and vertebral augmentation in the treatment of vertebral metastases: A multicenter study.

Revista espanola de cirugia ortopedica y traumatologia·2023
Same author

Major Fusarium species and mycotoxins associated with freshly harvested maize grain in Uruguay.

Mycotoxin research·2023
Same journal

Treatment of a Dialysate Leak by Simultaneous Catheter Removal and Replacement in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

A Rare Complication During Percutaneous Peritoneal Dialysis Catheter Insertion: Intravesical Placement.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Is It Safe to Initiate Peritoneal Dialysis Treatment Immediately After Percutaneous Catheter Placement?

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Better Healing of the Exit Site with Negative-Pressure Wound Therapy.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

When Love Hurts, It Leaves No Options! An Unusual Case of Pasteurella Peritoneal Dialysis Peritonitis Causing Severe Intra-abdominal Adhesions Preventing a Future Peritoneal Dialysis Option.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Neisseria mucosa Peritonitis in the Setting of a Migrated Intrauterine Device.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
See all related articles

The number of daily exchanges in continuous ambulatory peritoneal dialysis (CAPD) does not affect beta 2 microglobulin (beta 2 m) clearance. Serum beta 2 m levels are inversely related to residual renal function, increasing as kidney function declines.

Area of Science:

  • Nephrology
  • Biochemistry
  • Clinical Medicine

Background:

  • Beta 2 microglobulin (beta 2 m) is a protein removed by both the kidneys and peritoneal dialysis.
  • Understanding its clearance is crucial for managing End-Stage Renal Disease (ESRD).

Purpose of the Study:

  • To evaluate the impact of daily exchanges on peritoneal clearance (Kp) of beta 2 m in CAPD patients.
  • To identify factors influencing serum beta 2 m levels in these patients.

Main Methods:

  • Prospective study of 50 ESRD patients on CAPD.
  • Measurement of beta 2 m and creatinine clearance (renal and peritoneal) over 24 months.
  • Analysis of serum beta 2 m levels in relation to residual renal function (RRF) and dialysis parameters.

Related Experiment Videos

Main Results:

  • No significant difference in beta 2 m Kp between patients with 3 or 4 daily exchanges.
  • Serum beta 2 m levels were significantly lower in patients with RRF compared to those without (17 vs 38 mg/L).
  • Serum beta 2 m levels showed a strong inverse correlation with both renal clearance (Kr) of creatinine and beta 2 m.

Conclusions:

  • The number of daily CAPD exchanges does not influence beta 2 m Kp.
  • Serum beta 2 m levels are primarily influenced by residual renal function, decreasing as RRF is maintained.
  • Combined renal and peritoneal excretion of beta 2 m may be less than its daily production, leading to elevated levels with declining renal function.